Suzhou Sungent Industrial Development Co Ltd, a member within SIP-based comprehensive real estate developer Sungent Group, on Aug 6 signed an agreement with a local drug maker CStone Pharmaceutical to build an about-100,000㎡R&D and industrialization facility in SIP’s Dushu Lake Science & Education Innovation Zone for the latter.
It is learnt that CStone Pharmaceuticals, which was listed at Hong Kong Exchanges and Clearing Market in February, has achieved a robust development of anti-cancer drugs since its inception in SIP in 2015. The new project is expected to help the company enhance its R&D ability and quicken its pace for global expansion. Construction will start early next year.
Design sketch for the project
August 6, 2019